Paradromics
Pre-clinicalParadromics is developing breakthrough brain-computer interface technology to restore communication and independence for patients with severe paralysis from ALS, stroke, and spinal cord injury.
Founded
2015
Focus
NeuroscienceMedical Devices
About
Paradromics is developing breakthrough brain-computer interface technology to restore communication and independence for patients with severe paralysis from ALS, stroke, and spinal cord injury.
Funding History
3Total raised: $37.8M
Grant$18MNational Institutes of HealthJul 15, 2023
Series A$18MPrime Movers LabAug 15, 2021
Seed$1.8MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2015
LocationAustin, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile